WG Biotech ApS: Financial statements 2024
CVR: 36940131
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
WG Biotech ApS (CVR 36940131) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 45,114,000 and a net result of DKK 48,534,000 compared with DKK 48,874,000 the year before. That is a decrease of 7% compared with the year before. Equity in the 2024 report amounted to DKK 309,442,000. The solvency ratio was 97.1%.
- Gross Profit
- DKK 45,114,000
- Profit/Loss
- DKK 48,534,000
- Equity
- DKK 309,442,000
- Total Assets
- DKK 318,736,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 45.1 mio. | 48.5 mio. | 309.4 mio. | - |
| 2023 | - | 48.5 mio. | 48.9 mio. | 260.9 mio. | - |
| 2022 | - | -302.3 mio. | -300.2 mio. | 202.9 mio. | - |
| 2021 | - | -915.8 mio. | -913.9 mio. | 503.1 mio. | - |
| 2020 | - | - | 502.6 mio. | 1.6 mia. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
WG Biotech ApS has published its annual report for 2023. Gross profit came to DKK 48,499,000, and the net result was DKK 48,874,000.
About WG Biotech ApS
WG Biotech ApS is a Danish company of the type Anpartsselskab based in Rungsted Kyst, founded in 2015. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Johan Ernst Wedell-Wedellsborg. The company is owned by WECO A/S and WG Biotech ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,963,000 and a net result of DKK 2,166,000 compared with DKK 48,534,000 the year before. Equity in the 2025 report amounted to DKK 311,608,000.